Pangaea Oncology SA
MAD:PANG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pangaea Oncology SA
MAD:PANG
|
ES |
|
TXNM Energy Inc
NYSE:TXNM
|
US |
|
P
|
Pfizer Inc
SGO:PFE
|
US |
|
Madhav Marbles and Granites Ltd
NSE:MADHAV
|
IN |
|
F
|
Fraport Frankfurt Airport Services Worldwide AG
XMUN:FRA
|
DE |
|
Redcare Pharmacy NV
XETRA:RDC
|
NL |
|
National Gas and Industrialization Company SJSC
SAU:2080
|
SA |
|
GoldMoney Inc
TSX:XAU
|
CA |
|
F
|
Fujian Jinsen Forestry Co Ltd
SZSE:002679
|
CN |
Multiples-Based Value
The
Multiples-Based Value for
Pangaea Oncology SA (PANG)
under the Base Case is
hidden
EUR.
Compared with the current market price of 1.7 EUR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PANG Competitors Multiples
Pangaea Oncology SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ES |
|
Pangaea Oncology SA
MAD:PANG
|
58m EUR | 3.9 | -46.1 | 125.7 | -25.9 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
956.9B USD | 335.1 | 3 967.4 | 1 136.9 | 2 189.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
184.2B USD | 4.1 | 27.5 | 19.1 | 25.6 | |
| US |
|
Danaher Corp
NYSE:DHR
|
135B USD | 5.5 | 37.4 | 19 | 27.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
302.3B CNY | 6.6 | 15.8 | 16.5 | 16.5 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.5B CHF | 5.4 | 37.5 | 27.8 | 27.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.2B USD | 4.6 | 25 | 18.4 | 21.7 | |
| US |
|
Waters Corp
NYSE:WAT
|
30.2B USD | 9.5 | 46.9 | 30.3 | 38.1 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.9B USD | 1.8 | 21.4 | 11.9 | 17.8 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.9B USD | 6.4 | 29.7 | 22.1 | 24.5 |